Sanofi Receives FDA Approval for Qfitlia: A New Hope for Hemophilia Patients In a significant development for the hemophilia community, the U.S. Food and Drug Administration (FDA) has granted approval to Sanofi’s new drug, Qfitlia (fitusiran). This groundbreaking therapy distinguishes itself as the only treatment effective for all types of hemophilia, including both hemophilia A …
Continue reading “Sanofi’s Qfitlia Receives FDA Approval: A Game Changer for Hemophilia Treatment”